» Articles » PMID: 2505285

Sensitivity of Pentylenetetrazol Discrimination Increased by a Stimulus Fading Technique

Overview
Specialty Pharmacology
Date 1989 Jan 1
PMID 2505285
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The interoceptive stimulus produced by pentylenetetrazol (PTZ) is pharmacologically similar to anxiety and is used in a behavioral assay for anxiety-related stimuli (the PTZ model of anxiety). The stimulus fading technique was tested as a method to increase the sensitivity of this assay. Rats were trained with food-reward to press one lever after injection of PTZ and an alternate lever after saline. Rats initially learned the discrimination at a PTZ dose of 20 mg/kg. They were then trained with sequentially lower doses until they reliably discriminated a PTZ dose of 10 mg/kg. Substitution tests with other doses and drugs showed that, after the fading procedure, dose-response curves were shifted to lower doses for PTZ, Ro 5-3663, and nicotine Similarly, the dose of diazepam required to block the low dose of PTZ was lower than that required to block the higher dose of PTZ. These results indicated that the sensitivity of the discrimination was enhanced in rats trained to discriminate a lower dose of PTZ. Doses of nikethamide, cocaine, and yohimbine that did not substitute for the higher dose of PTZ also did not substitute for the lower dose. These data suggest that rats can be trained to discriminate a low dose of PTZ by the stimulus fading technique. Moreover, they suggest that this training method does not compromise the specificity of the discrimination.

Citing Articles

Effects of ethanol on cocaine discrimination in rats.

Gatch M, Youngblood B, Forster M Pharmacol Biochem Behav. 2003; 75(4):837-44.

PMID: 12957226 PMC: 3878080. DOI: 10.1016/s0091-3057(03)00158-8.


Drug discrimination by humans compared to nonhumans: current status and future directions.

Kamien J, Bickel W, Hughes J, Higgins S, Smith B Psychopharmacology (Berl). 1993; 111(3):259-70.

PMID: 7870962 DOI: 10.1007/BF02244940.


Animal models of drug withdrawal symptoms.

Mathis D, Moon R, Lal H Psychopharmacology (Berl). 1990; 101(3):292-309.

PMID: 1972994 DOI: 10.1007/BF02244046.

References
1.
Peto R, Pike M, Day N, Gray R, Lee P, Parish S . Guidelines for simple, sensitive significance tests for carcinogenic effects in long-term animal experiments. IARC Monogr Eval Carcinog Risk Chem Hum Suppl. 1980; (2 Suppl):311-426. View

2.
Lal H . Behavioral analogues of anxiety. Animal models. Neuropharmacology. 1983; 22(12B):1423-41. DOI: 10.1016/0028-3908(83)90111-9. View

3.
Harris C, Mathis D, Lal H . Quantal detection and homogeneous sensitivity in a pentylenetetrazol discrimination. Psychopharmacology (Berl). 1988; 94(2):183-7. DOI: 10.1007/BF00176842. View

4.
Stolerman I, Garcha H, Pratt J, Kumar R . Role of training dose in discrimination of nicotine and related compounds by rats. Psychopharmacology (Berl). 1984; 84(3):413-9. DOI: 10.1007/BF00555223. View

5.
Colpaert F, NIEMEGEERS C, Janssen P . Factors regulating drug cue sensitivity: limits of discriminability and the role of a progressively decreasing training dose in fentanyl-saline discrimination. J Pharmacol Exp Ther. 1980; 212(3):474-80. View